Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge

F Violi, D Pastori, R Cangemi… - Thrombosis and …, 2020 - thieme-connect.com
The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Diet supplementation, probiotics, and nutraceuticals in SARS-CoV-2 infection: a scoping review

F Infusino, M Marazzato, M Mancone, F Fedele… - Nutrients, 2020 - mdpi.com
The severe acute respiratory syndrome coronavirus 2 (Sars-CoV-2) global pandemic is a
devastating event that is causing thousands of victims every day around the world. One of …

Isoprostanes, neuroprostanes and phytoprostanes: An overview of 25 years of research in chemistry and biology

JM Galano, YY Lee, C Oger, C Vigor… - Progress in lipid …, 2017 - Elsevier
Since the beginning of the 1990's diverse types of metabolites originating from
polyunsaturated fatty acids, formed under autooxidative conditions were discovered. Known …

Fisiopatología de la enfermedad cardiovascular en pacientes con COVID-19. Isquemia, trombosis y disfunción cardiaca

J Rozado, A Ayesta, C Morís, P Avanzas - Revista Española de Cardiología …, 2020 - Elsevier
Las complicaciones cardiovasculares tienen una alta prevalencia en los pacientes con
COVID-19 y son motivo frecuente de hospitalización, mortalidad y secuelas. En está …

Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production

C Nocella, R Carnevale, S Bartimoccia… - Thrombosis and …, 2017 - thieme-connect.com
The effect of lipopolysaccharide (LPS) on platelet aggregation is still controversial. We
performed in vitro and ex vivo studies in controls and in patients with community-acquired …

[HTML][HTML] Endothelial dysfunction, oxidative stress and low-grade endotoxemia in COVID-19 patients hospitalised in medical wards

P Ciacci, A Paraninfi, F Orlando, S Rella, E Maggio… - Microvascular …, 2023 - Elsevier
Background Endothelial dysfunction, assessed by flow-mediated dilation (FMD), is related to
poor prognosis in patients with COVID-19 pneumonia (CP). In this study, we explored the …

Corticosteroid use and incident myocardial infarction in adults hospitalized for community-acquired pneumonia

R Cangemi, M Falcone, G Taliani… - Annals of the …, 2019 - atsjournals.org
Rationale: Adults hospitalized for community-acquired pneumonia (CAP) have an increased
risk of myocardial infarction. Corticosteroid treatment lowers CAP morbidity and mortality, but …

Carotid intima-media thickness and flow-mediated dilation do not predict acute in-hospital outcomes in patients hospitalized with COVID-19

M Cristina-Oliveira, K Meireles, S Gil… - American Journal …, 2022 - journals.physiology.org
Studies have suggested a potential role of endothelial dysfunction and atherosclerosis in the
pathophysiology of COVID-19. Herein, we tested whether brachial flow-mediated dilation …

[HTML][HTML] Hypoalbuminemia as predictor of thrombotic events in patients with community-acquired pneumonia

E Valeriani, R Cangemi, R Carnevale, GF Romiti… - International Journal of …, 2024 - Elsevier
Background Hypoalbuminemia complicates acute diseases and infections and is associated
with a worst prognosis. The aim is to evaluate whether hypoalbuminemia is associated with …

Use of nonsteroidal anti-inflammatory drugs for COVID-19 infection: Adjunct therapy?

D Zhao, S Zhang, T Igawa, W Frishman - Cardiology in review, 2020 - journals.lww.com
Severe acute respiratory distress syndrome coronavirus 2 (COVID-19) is the cause of the
current pandemic, which remains a tremendous cause of morbidity and mortality worldwide …